Sam-A Pharm. Co., Ltd (KOSDAQ: A009300)
Health Care · Pharmaceuticals · KR
₩13,690.00
+0.81% today · -21.5% 1Y
Sam-A Pharm. Co., Ltd (KOSDAQ: A009300) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $60.29M.
Over the last twelve months the share price has lost 21.5%, trading between 11.95K and 17.48K.
Tweenvest scores Sam-A Pharm. Co., Ltd across four factors: quality 70/100, value 71/100, dividend 90/100. Its strongest factor is dividend.
A009300 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $60.29M
- Revenue (TTM)
- $46.68M
- P/E
- 7.93
- EPS
- 1,727.34
- Dividend yield
- 6.21%
- Beta (5Y)
- 0.17
- 52-week high
- ₩17,480.00
- 52-week low
- ₩11,950.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.10M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,257.13 | +0.82% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $272.92 | -0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $154.01 | +2.22% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.44 | +1.68% |
Figures last refreshed Aug 18, 2026.